Publication of the first human clinical trial results on Urolithin A (Anti-Aging Compound).
LAUSANNE, Switzerland–(BUSINESS WIRE).
Nature Metabolism published a breakthrough translational science on the effects of Urolithin A – a pomegranate metabolism metabolite – on mitochondrial health and cellular function in humans.
Amazentis is an innovative life sciences firm that pioneers scientific breakthroughs to manage conditions related to aging. Today, the company announced a collaboration publication in Nature Metabolism, with scientists from the Ecole Polytechnique Federale de Lausanne and Swiss Institute of Bioinformatics. The article demonstrates the Company’s leading product, Urolithin A, is safe, bioavailable, and improves mitochondrial health and cellular health.
Source:
https://finance.yahoo.com/news/first-human-clinical-trial-results-150000066.html
